Clinical Trial Update: A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin [Phase 2]

View source ↗

Summary

Phase 2 trial update of Roche investigational agents RO5093151 and RO5027838 in patients with type 2 diabetes mellitus on a stable metformin regimen. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO5027838
• RO5093151

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED